| Year |
Citation |
Score |
| 2020 |
Pinson A, Yarbrough AL, Bush JM, Cabanlong CV, Shoeib A, Jackson BK, Fukuda S, Gogoi J, Fantegrossi WE, McCain K, Prather PL, Fujiwara R, Radominska-Pandya A. Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity. Pharmacology, Biochemistry, and Behavior. 172949. PMID 32413436 DOI: 10.1016/J.Pbb.2020.172949 |
0.41 |
|
| 2019 |
Jones S, Yarbrough AL, Shoeib A, Bush JM, Fantegrossi WE, Prather PL, Radominska-Pandya A, Fujiwara R. Enzymatic Analysis of Glucuronidation of Synthetic Cannabinoid 1-Naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22). Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 1-25. PMID 30739533 DOI: 10.1080/00498254.2019.1580403 |
0.389 |
|
| 2019 |
Yarbrough A, Fujiwara R, Fantegrossi W, Prather P, Radominska-Pandya A. Oxidative metabolism of synthetic cannabinoid STS-135 by recombinant P450S and human liver microsomes Drug Metabolism and Pharmacokinetics. 34: S28. DOI: 10.1016/J.Dmpk.2018.09.111 |
0.355 |
|
| 2018 |
Wilson CD, Tai S, Ewing L, Crane J, Lockhart T, Yarbrough AL, Fujiwara R, Radominska-Pandya A, Fantegrossi WE. Convulsant effects of abused synthetic cannabinoids JWH-018 and 5F-AB-PINACA are mediated by agonist actions at CB1 receptors in mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 30420360 DOI: 10.1124/Jpet.118.251157 |
0.333 |
|
| 2018 |
Hutchison RD, Ford BM, Franks LN, Wilson CD, Yarbrough AL, Fujiwara R, Su MK, Fernandez D, James LP, Moran JH, Patton AL, Fantegrossi WE, Radominska-Pandya A, Prather PL. Atypical Pharmacodynamic Properties and Metabolic Profile of the Abused Synthetic Cannabinoid AB-PINACA: Potential Contribution to Pronounced Adverse Effects Relative to Δ-THC. Frontiers in Pharmacology. 9: 1084. PMID 30319418 DOI: 10.3389/Fphar.2018.01084 |
0.375 |
|
| 2018 |
Patton AL, Seely KA, Yarbrough AL, Fantegrossi W, James LP, McCain KR, Fujiwara R, Prather PL, Moran JH, Radominska-Pandya A. Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants. Biochemical and Biophysical Research Communications. PMID 29522717 DOI: 10.1016/J.Bbrc.2018.03.028 |
0.412 |
|
| 2016 |
Ford BM, Franks LN, Radominska-Pandya A, Prather PL. Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development. Plos One. 11: e0167240. PMID 27936172 DOI: 10.1371/Journal.Pone.0167240 |
0.385 |
|
| 2015 |
Dates CR, Fahmi T, Pyrek SJ, Yao-Borengasser A, Borowa-Mazgaj B, Bratton SM, Kadlubar SA, Mackenzie PI, Haun RS, Radominska-Pandya A. Human UDP-Glucuronosyltransferases: Effects of altered expression in breast and pancreatic cancer cell lines. Cancer Biology & Therapy. 16: 714-23. PMID 25996841 DOI: 10.1080/15384047.2015.1026480 |
0.336 |
|
| 2014 |
Saeed LM, Mahmood M, Pyrek SJ, Fahmi T, Xu Y, Mustafa T, Nima ZA, Bratton SM, Casciano D, Dervishi E, Radominska-Pandya A, Biris AS. Single-walled carbon nanotube and graphene nanodelivery of gambogic acid increases its cytotoxicity in breast and pancreatic cancer cells. Journal of Applied Toxicology : Jat. 34: 1188-99. PMID 25220893 DOI: 10.1002/Jat.3018 |
0.321 |
|
| 2014 |
Greer AK, Dates CR, Starlard-Davenport A, Edavana VK, Bratton SM, Dhakal IB, Finel M, Kadlubar SA, Radominska-Pandya A. A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 1392-400. PMID 24917585 DOI: 10.1124/Dmd.114.058016 |
0.682 |
|
| 2014 |
Greer AK, Madadi NR, Bratton SM, Eddy SD, Mazerska Z, Hendrickson HP, Crooks PA, Radominska-Pandya A. Novel resveratrol-based substrates for human hepatic, renal, and intestinal UDP-glucuronosyltransferases. Chemical Research in Toxicology. 27: 536-45. PMID 24571610 DOI: 10.1021/Tx400408X |
0.418 |
|
| 2014 |
Fantegrossi WE, Moran JH, Radominska-Pandya A, Prather PL. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Life Sciences. 97: 45-54. PMID 24084047 DOI: 10.1016/J.Lfs.2013.09.017 |
0.325 |
|
| 2013 |
Chimalakonda KC, James LP, Radominska-Pandya A, Moran JH. Sulfaphenazole and α-naphthoflavone attenuate the metabolism of the synthetic cannabinoids JWH-018 and AM2201 found in K2/spice. Drug Metabolism Letters. 7: 34-8. PMID 24329780 DOI: 10.2174/187231280701131211151523 |
0.392 |
|
| 2013 |
Prather PL, FrancisDevaraj F, Dates CR, Greer AK, Bratton SM, Ford BM, Franks LN, Radominska-Pandya A. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen. Biochemical and Biophysical Research Communications. 441: 339-43. PMID 24148245 DOI: 10.1016/J.Bbrc.2013.10.057 |
0.381 |
|
| 2013 |
Patton AL, Seely KA, Chimalakonda KC, Tran JP, Trass M, Miranda A, Fantegrossi WE, Kennedy PD, Dobrowolski P, Radominska-Pandya A, McCain KR, James LP, Endres GW, Moran JH. Targeted metabolomic approach for assessing human synthetic cannabinoid exposure and pharmacology. Analytical Chemistry. 85: 9390-9. PMID 23987522 DOI: 10.1021/Ac4024704 |
0.392 |
|
| 2013 |
Pawlowska M, Chu R, Fedejko-Kap B, Augustin E, Mazerska Z, Radominska-Pandya A, Chambers TC. Metabolic transformation of antitumor acridinone C-1305 but not C-1311 via selective cellular expression of UGT1A10 increases cytotoxic response: implications for clinical use. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 41: 414-21. PMID 23160818 DOI: 10.1124/Dmd.112.047811 |
0.32 |
|
| 2012 |
Chimalakonda KC, Seely KA, Bratton SM, Brents LK, Moran CL, Endres GW, James LP, Hollenberg PF, Prather PL, Radominska-Pandya A, Moran JH. Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 2174-84. PMID 22904561 DOI: 10.1124/Dmd.112.047530 |
0.446 |
|
| 2012 |
Fedejko-Kap B, Bratton SM, Finel M, Radominska-Pandya A, Mazerska Z. Role of human UDP-glucuronosyltransferases in the biotransformation of the triazoloacridinone and imidazoacridinone antitumor agents C-1305 and C-1311: highly selective substrates for UGT1A10. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1736-43. PMID 22659092 DOI: 10.1124/Dmd.112.045401 |
0.418 |
|
| 2012 |
Seely KA, Brents LK, Radominska-Pandya A, Endres GW, Keyes GS, Moran JH, Prather PL. A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors. Chemical Research in Toxicology. 25: 825-7. PMID 22404317 DOI: 10.1021/Tx3000472 |
0.366 |
|
| 2012 |
Bratton SM, Mosher CM, Khallouki F, Finel M, Court MH, Moran JH, Radominska-Pandya A. Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases. The Journal of Pharmacology and Experimental Therapeutics. 340: 46-55. PMID 21972237 DOI: 10.1124/Jpet.111.184721 |
0.351 |
|
| 2012 |
Brents LK, Medina-Bolivar F, Seely KA, Nair V, Bratton SM, Nopo-Olazabal L, Patel RY, Liu H, Doerksen RJ, Prather PL, Radominska-Pandya A. Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 42: 139-56. PMID 21970716 DOI: 10.3109/00498254.2011.609570 |
0.345 |
|
| 2011 |
Fedejko-Kap B, Niemira M, Radominska-Pandya A, Mazerska Z. Flavin monooxygenases, FMO1 and FMO3, not cytochrome P450 isoenzymes, contribute to metabolism of anti-tumour triazoloacridinone, C-1305, in liver microsomes and HepG2 cells. Xenobiotica; the Fate of Foreign Compounds in Biological Systems. 41: 1044-55. PMID 21859392 DOI: 10.3109/00498254.2011.604743 |
0.367 |
|
| 2011 |
Höglund C, Sneitz N, Radominska-Pandya A, Laakonen L, Finel M. Phenylalanine 93 of the human UGT1A10 plays a major role in the interactions of the enzyme with estrogens. Steroids. 76: 1465-73. PMID 21846474 DOI: 10.1016/J.Steroids.2011.07.017 |
0.359 |
|
| 2011 |
Chimalakonda KC, Bratton SM, Le VH, Yiew KH, Dineva A, Moran CL, James LP, Moran JH, Radominska-Pandya A. Conjugation of synthetic cannabinoids JWH-018 and JWH-073, metabolites by human UDP-glucuronosyltransferases. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 39: 1967-76. PMID 21746969 DOI: 10.1124/Dmd.111.040709 |
0.357 |
|
| 2011 |
Chimalakonda KC, Moran CL, Kennedy PD, Endres GW, Uzieblo A, Dobrowolski PJ, Fifer EK, Lapoint J, Nelson LS, Hoffman RS, James LP, Radominska-Pandya A, Moran JH. Solid-phase extraction and quantitative measurement of omega and omega-1 metabolites of JWH-018 and JWH-073 in human urine. Analytical Chemistry. 83: 6381-8. PMID 21740038 DOI: 10.1021/Ac201377M |
0.348 |
|
| 2011 |
Moran CL, Le VH, Chimalakonda KC, Smedley AL, Lackey FD, Owen SN, Kennedy PD, Endres GW, Ciske FL, Kramer JB, Kornilov AM, Bratton LD, Dobrowolski PJ, Wessinger WD, Fantegrossi WE, ... ... Radominska-Pandya A, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine Analytical Chemistry. 83: 4228-4236. PMID 21506519 DOI: 10.1021/Ac2005636 |
0.313 |
|
| 2010 |
Radominska-Pandya A, Bratton SM, Redinbo MR, Miley MJ. The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families. Drug Metabolism Reviews. 42: 133-44. PMID 19821783 DOI: 10.3109/03602530903209049 |
0.38 |
|
| 2009 |
Miller GP, Jones DR, Sullivan SZ, Mazur A, Owen SN, Mitchell NC, Radominska-Pandya A, Moran JH. Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humans. Chemical Research in Toxicology. 22: 1239-45. PMID 19408964 DOI: 10.1021/Tx900031Z |
0.373 |
|
| 2009 |
Mazur A, Lichti CF, Prather PL, Zielinska AK, Bratton SM, Gallus-Zawada A, Finel M, Miller GP, Radomińska-Pandya A, Moran JH. Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 1496-504. PMID 19339377 DOI: 10.1124/Dmd.109.026898 |
0.432 |
|
| 2009 |
Itäaho K, Court MH, Uutela P, Kostiainen R, Radominska-Pandya A, Finel M. Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 768-75. PMID 19116261 DOI: 10.1124/Dmd.108.025692 |
0.334 |
|
| 2009 |
Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A. Erratum to “Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues” [Steroids 73 (6) (2008) 611–620] Steroids. 74: 548-549. DOI: 10.1016/J.Steroids.2008.09.001 |
0.643 |
|
| 2008 |
Lu Y, Bratton S, Heydel JM, Radominska-Pandya A. Effect of retinoids on UDP-glucuronosyltransferase 2B7 mRNA expression in Caco-2 cells. Drug Metabolism and Pharmacokinetics. 23: 364-72. PMID 18974614 DOI: 10.2133/Dmpk.23.364 |
0.365 |
|
| 2008 |
Miller GP, Lichti CF, Zielinska AK, Mazur A, Bratton SM, Gallus-Zawada A, Finel M, Moran JH, Radominska-Pandya A. Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarin. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 2211-8. PMID 18725508 DOI: 10.1124/Dmd.108.022863 |
0.412 |
|
| 2008 |
Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A. Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues. Steroids. 73: 611-20. PMID 18374377 DOI: 10.1016/J.Steroids.2008.01.019 |
0.642 |
|
| 2008 |
Xiong Y, Patana AS, Miley MJ, Zielinska AK, Bratton SM, Miller GP, Goldman A, Finel M, Redinbo MR, Radominska-Pandya A. The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 36: 517-22. PMID 18048489 DOI: 10.1124/Dmd.107.016469 |
0.364 |
|
| 2008 |
Starlard-Davenport A, Lyn-Cook B, Radominska-Pandya A. Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids. 73: 139-47. PMID 17981312 DOI: 10.1016/J.Steroids.2007.09.007 |
0.644 |
|
| 2008 |
Zielinska A, Lichti CF, Bratton S, Mitchell NC, Gallus-Zawada A, Le VH, Finel M, Miller GP, Radominska-Pandya A, Moran JH. Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases. The Journal of Pharmacology and Experimental Therapeutics. 324: 139-48. PMID 17921187 DOI: 10.1124/Jpet.107.129858 |
0.434 |
|
| 2007 |
Li X, Bratton S, Radominska-Pandya A. Human UGT1A8 and UGT1A10 mRNA are expressed in primary human hepatocytes. Drug Metabolism and Pharmacokinetics. 22: 152-61. PMID 17603215 DOI: 10.2133/Dmpk.22.152 |
0.354 |
|
| 2007 |
Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR. Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. Journal of Molecular Biology. 369: 498-511. PMID 17442341 DOI: 10.1016/J.Jmb.2007.03.066 |
0.395 |
|
| 2007 |
Collom SL, Jamakhandi AP, Tackett AJ, Radominska-Pandya A, Miller GP. CYP2E1 active site residues in substrate recognition sequence 5 identified by photoaffinity labeling and homology modeling. Archives of Biochemistry and Biophysics. 459: 59-69. PMID 17222385 DOI: 10.1016/J.Abb.2006.10.028 |
0.322 |
|
| 2007 |
Starlard-Davenport A, Xiong Y, Bratton S, Gallus-Zawada A, Finel M, Radominska-Pandya A. Phenylalanine(90) and phenylalanine(93) are crucial amino acids within the estrogen binding site of the human UDP-glucuronosyltransferase 1A10. Steroids. 72: 85-94. PMID 17174996 DOI: 10.1016/J.Steroids.2006.11.016 |
0.658 |
|
| 2006 |
Ronis MJ, Little JM, Barone GW, Chen G, Radominska-Pandya A, Badger TM. Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. Journal of Medicinal Food. 9: 348-55. PMID 17004897 DOI: 10.1089/Jmf.2006.9.348 |
0.403 |
|
| 2006 |
Sabolovic N, Humbert AC, Radominska-Pandya A, Magdalou J. Resveratrol is efficiently glucuronidated by UDP-glucuronosyltransferases in the human gastrointestinal tract and in Caco-2 cells. Biopharmaceutics & Drug Disposition. 27: 181-9. PMID 16477579 DOI: 10.1002/Bdd.498 |
0.356 |
|
| 2006 |
Xiong Y, Bernardi D, Bratton S, Ward MD, Battaglia E, Finel M, Drake RR, Radominska-Pandya A. Phenylalanine 90 and 93 are localized within the phenol binding site of human UDP-glucuronosyltransferase 1A10 as determined by photoaffinity labeling, mass spectrometry, and site-directed mutagenesis. Biochemistry. 45: 2322-32. PMID 16475821 DOI: 10.1021/Bi0519001 |
0.355 |
|
| 2005 |
Finel M, Li X, Gardner-Stephen D, Bratton S, Mackenzie PI, Radominska-Pandya A. Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity. The Journal of Pharmacology and Experimental Therapeutics. 315: 1143-9. PMID 16120810 DOI: 10.1124/Jpet.105.091900 |
0.434 |
|
| 2005 |
Radominska-Pandya A, Bratton S, Little JM. A historical overview of the heterologous expression of mammalian UDP-glucuronosyltransferase isoforms over the past twenty years. Current Drug Metabolism. 6: 141-60. PMID 15853765 DOI: 10.2174/1389200053586127 |
0.356 |
|
| 2005 |
Lu Y, Heydel JM, Li X, Bratton S, Lindblom T, Radominska-Pandya A. Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 33: 937-46. PMID 15821044 DOI: 10.1124/Dmd.104.003061 |
0.371 |
|
| 2004 |
Sabolovic N, Heydel JM, Li X, Little JM, Humbert AC, Radominska-Pandya A, Magdalou J. Carboxyl nonsteroidal anti-inflammatory drugs are efficiently glucuronidated by microsomes of the human gastrointestinal tract. Biochimica Et Biophysica Acta. 1675: 120-9. PMID 15535975 DOI: 10.1016/J.Bbagen.2004.08.013 |
0.401 |
|
| 2004 |
Little JM, Kurkela M, Sonka J, Jäntti S, Ketola R, Bratton S, Finel M, Radominska-Pandya A. Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases. Journal of Lipid Research. 45: 1694-703. PMID 15231852 DOI: 10.1194/Jlr.M400103-Jlr200 |
0.393 |
|
| 2004 |
Xie W, Uppal H, Saini SP, Mu Y, Little JM, Radominska-Pandya A, Zemaitis MA. Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. Drug Discovery Today. 9: 442-9. PMID 15109949 DOI: 10.1016/S1359-6446(04)03061-2 |
0.359 |
|
| 2004 |
Gardner-Stephen D, Heydel JM, Goyal A, Lu Y, Xie W, Lindblom T, Mackenzie P, Radominska-Pandya A. Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 32: 340-7. PMID 14977869 DOI: 10.1124/Dmd.32.3.340 |
0.369 |
|
| 2003 |
Mackenzie PI, Gregory PA, Gardner-Stephen DA, Lewinsky RH, Jorgensen BR, Nishiyama T, Xie W, Radominska-Pandya A. Regulation of UDP glucuronosyltransferase genes. Current Drug Metabolism. 4: 249-57. PMID 12769669 DOI: 10.2174/1389200033489442 |
0.316 |
|
| 2003 |
Chen G, Zhang D, Jing N, Yin S, Falany CN, Radominska-Pandya A. Human gastrointestinal sulfotransferases: identification and distribution. Toxicology and Applied Pharmacology. 187: 186-97. PMID 12662902 DOI: 10.1016/S0041-008X(02)00073-X |
0.37 |
|
| 2003 |
Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, Evans RM. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proceedings of the National Academy of Sciences of the United States of America. 100: 4150-5. PMID 12644700 DOI: 10.1073/Pnas.0438010100 |
0.368 |
|
| 2003 |
Antonio L, Xu J, Little JM, Burchell B, Magdalou J, Radominska-Pandya A. Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7. Archives of Biochemistry and Biophysics. 411: 251-61. PMID 12623074 DOI: 10.1016/S0003-9861(02)00748-8 |
0.355 |
|
| 2003 |
Mackenzie P, Little JM, Radominska-Pandya A. Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochemical Pharmacology. 65: 417-21. PMID 12527334 DOI: 10.1016/S0006-2952(02)01522-8 |
0.342 |
|
| 2002 |
Mehta KD, Radominska-Pandya A, Kapoor GS, Dave B, Atkins BA. Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol. Molecular and Cellular Biology. 22: 3783-93. PMID 11997513 DOI: 10.1128/Mcb.22.11.3783-3793.2002 |
0.307 |
|
| 2002 |
Little JM, Williams L, Xu J, Radominska-Pandya A. Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 30: 531-3. PMID 11950783 DOI: 10.1124/Dmd.30.5.531 |
0.4 |
|
| 2002 |
Radominska-Pandya A, Chen G. Photoaffinity labeling of human retinoid X receptor beta (RXRbeta) with 9-cis-retinoic acid: identification of phytanic acid, docosahexaenoic acid, and lithocholic acid as ligands for RXRbeta. Biochemistry. 41: 4883-90. PMID 11939783 DOI: 10.1021/Bi0121151 |
0.301 |
|
| 2002 |
Radominska-Pandya A, Pokrovskaya ID, Xu J, Little JM, Jude AR, Kurten RC, Czernik PJ. Nuclear UDP-glucuronosyltransferases: identification of UGT2B7 and UGT1A6 in human liver nuclear membranes. Archives of Biochemistry and Biophysics. 399: 37-48. PMID 11883901 DOI: 10.1006/Abbi.2001.2743 |
0.306 |
|
| 2002 |
Radominska-Pandya A, Little JM, Czernik PJ. Human UDP-glucuronosyltransferase 2B7. Current Drug Metabolism. 2: 283-98. PMID 11513331 DOI: 10.2174/1389200013338379 |
0.422 |
|
| 2001 |
Jude AR, Little JM, Czernik PJ, Tephly TR, Grant DF, Radominska-Pandya A. Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: identification of UGT2B7 as the major isoform involved. Archives of Biochemistry and Biophysics. 389: 176-86. PMID 11339806 DOI: 10.1006/Abbi.2001.2344 |
0.378 |
|
| 2001 |
Radominska-Pandya A, Chen G, Samokyszyn VM, Little JM, Gall WE, Zawada G, Terrier N, Magdalou J, Czernik P. Application of photoaffinity labeling with [(3)H] all trans- and 9-cis-retinoic acids for characterization of cellular retinoic acid--binding proteins I and II. Protein Science : a Publication of the Protein Society. 10: 200-11. PMID 11266607 DOI: 10.1110/Ps.26501 |
0.322 |
|
| 2001 |
Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, Waxman DJ, Evans RM. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proceedings of the National Academy of Sciences of the United States of America. 98: 3375-80. PMID 11248086 DOI: 10.1073/Pnas.051014398 |
0.378 |
|
| 2000 |
Chen G, Rabjohn PA, York JL, Wooldridge C, Zhang D, Falany CN, Radominska-Pandya A. Carboxyl residues in the active site of human phenol sulfotransferase (SULT1A1). Biochemistry. 39: 16000-7. PMID 11123927 DOI: 10.1021/Bi0021479 |
0.365 |
|
| 2000 |
Chen G, Radominska-Pandya A. Direct photoaffinity labeling of cellular retinoic acid-binding protein I (CRABP-I) with all-trans-retinoic acid: identification of amino acids in the ligand binding site. Biochemistry. 39: 12568-74. PMID 11027136 DOI: 10.1021/Bi000321N |
0.31 |
|
| 2000 |
Jude AR, Little JM, Freeman JP, Evans JE, Radominska-Pandya A, Grant DF. Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases. Archives of Biochemistry and Biophysics. 380: 294-302. PMID 10933884 DOI: 10.1006/Abbi.2000.1933 |
0.389 |
|
| 2000 |
Tessier DC, Dignard D, Zapun A, Radominska-Pandya A, Parodi AJ, Bergeron JJ, Thomas DY. Cloning and characterization of mammalian UDP-glucose glycoprotein: glucosyltransferase and the development of a specific substrate for this enzyme. Glycobiology. 10: 403-12. PMID 10764828 DOI: 10.1093/Glycob/10.4.403 |
0.328 |
|
| 2000 |
Radominska-Pandya A, Chen G, Czernik PJ, Little JM, Samokyszyn VM, Carter CA, Nowak Gd. Direct interaction of all-trans-retinoic acid with protein kinase C (PKC). Implications for PKC signaling and cancer therapy. The Journal of Biological Chemistry. 275: 22324-30. PMID 10748087 DOI: 10.1074/Jbc.M907722199 |
0.336 |
|
| 2000 |
Samokyszyn VM, Gall WE, Zawada G, Freyaldenhoven MA, Chen G, Mackenzie PI, Tephly TR, Radominska-Pandya A. 4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7. The Journal of Biological Chemistry. 275: 6908-14. PMID 10702251 DOI: 10.1074/Jbc.275.10.6908 |
0.36 |
|
| 2000 |
Chen G, Battaglia E, Senay C, Falany CN, Radominska-Pandya A. Photoaffinity labeling probe for the substrate binding site of human phenol sulfotransferase (SULT1A1): 7-azido-4-methylcoumarin. Protein Science : a Publication of the Protein Society. 8: 2151-7. PMID 10548061 DOI: 10.1110/Ps.8.10.2151 |
0.345 |
|
| 1999 |
Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI. Structural and functional studies of UDP-glucuronosyltransferases. Drug Metabolism Reviews. 31: 817-99. PMID 10575553 DOI: 10.1081/Dmr-100101944 |
0.346 |
|
| 1999 |
Gall WE, Zawada G, Mojarrabi B, Tephly TR, Green MD, Coffman BL, Mackenzie PI, Radominska-Pandya A. Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7. The Journal of Steroid Biochemistry and Molecular Biology. 70: 101-8. PMID 10529008 DOI: 10.1016/S0960-0760(99)00088-6 |
0.37 |
|
| 1999 |
Senay C, Battaglia E, Chen G, Breton R, Fournel-Gigleux S, Magdalou J, Radominska-Pandya A. Photoaffinity labeling of the aglycon binding site of the recombinant human liver UDP-glucuronosyltransferase UGT1A6 with 7-azido-4-methylcoumarin. Archives of Biochemistry and Biophysics. 368: 75-84. PMID 10415114 DOI: 10.1006/Abbi.1999.1300 |
0.384 |
|
| 1999 |
Nowell SA, Massengill JS, Williams S, Radominska-Pandya A, Tephly TR, Cheng Z, Strassburg CP, Tukey RH, MacLeod SL, Lang NP, Kadlubar FF. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis. 20: 1107-14. PMID 10357796 DOI: 10.1093/Carcin/20.6.1107 |
0.371 |
|
| 1999 |
Little JM, Lester R, Kuipers F, Vonk R, Mackenzie PI, Drake RR, Frame L, Radominska-Pandya A. Variability of human hepatic UDP-glucuronosyltransferase activity. Acta Biochimica Polonica. 46: 351-363. DOI: 10.18388/Abp.1999_4168 |
0.389 |
|
| 1999 |
Terrier N, Benoit E, Senay C, Lapicque F, Radominska-Pandya A, Magdalou J, Fournel-Gigleux S. Human and Rat Liver UDP-Glucuronosyltransferases Are Targets of Ketoprofen Acylglucuronide Molecular Pharmacology. 56: 226-234. DOI: 10.1124/Mol.56.1.226 |
0.376 |
|
| 1998 |
Radominska-Pandya A, Little JM, Pandya JT, Tephly TR, King CD, Barone GW, Raufman JP. UDP-glucuronosyltransferases in human intestinal mucosa. Biochimica Et Biophysica Acta. 1394: 199-208. PMID 9795217 DOI: 10.1016/S0005-2760(98)00115-5 |
0.409 |
|
| 1998 |
Cheng Z, Radominska-Pandya A, Tephly TR. Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8. Archives of Biochemistry and Biophysics. 356: 301-5. PMID 9705221 DOI: 10.1006/Abbi.1998.0781 |
0.403 |
|
| 1998 |
Battaglia E, Radominska-Pandya A. A functional role for histidyl residues of the UDP-glucuronic acid carrier in rat liver endoplasmic reticulum membranes. Biochemistry. 37: 258-63. PMID 9425046 DOI: 10.1021/Bi9716332 |
0.35 |
|
| Show low-probability matches. |